000047645 000__ 03542nam\a2200493\i\4500
000047645 001__ 47645
000047645 003__ SzGeWIPO
000047645 005__ 20230322180815.0
000047645 006__ m\\\\e\\\d\\\\\\\\
000047645 007__ cr bn |||m|||a
000047645 008__ 230320s2022\\\\enk\\\\\\\\\\\001\0\eng\d
000047645 020__ $$a9781800884410$$qeBook
000047645 020__ $$z9781800884403$$qPrint
000047645 035__ $$aeep9781800884410
000047645 035__ $$a(OCoLC)1373643391
000047645 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000047645 041__ $$aeng
000047645 042__ $$apcc
000047645 043__ $$ae------
000047645 050_4 $$aLCC
000047645 08204 $$a660.60272$$223
000047645 08204 $$a660.60272$$220
000047645 24500 $$aPatenting Biotechnical Innovation :$$bEligibility, Ethics and Public Interest.
000047645 264_1 $$a[Northampton, England] :$$bEdward Elgar Publishing Ltd.,$$c2022.
000047645 300__ $$a224 pages.
000047645 336__ $$atext$$btxt$$2rdacontent
000047645 337__ $$aunmediated$$bn$$2rdamedia
000047645 338__ $$avolume$$bnc$$2rdacarrier
000047645 500__ $$aIncludes index.
000047645 5050_ $$a1. Introduction -- patenting biotechnical innovation: in the public interest? -- 2. Patent eligibility and precision medicine: emerging technologies, legal flux and empirical methods -- 3. Non-invasive prenatal testing and the resilience of the patent system -- 4. Patentability of biofabricated human organs: ‘products of nature’ or ‘products derived from nature’ revisited -- 5. A problem of interpretation: is Article 53(a) EPC necessarily restrictive of emerging technologies? -- 6. Invoking the public interest in the European patent system -- 7. Repositioning the access to healthcare debate: FRAND and the Internet of Medical Things -- 8. Accounting for ethical considerations in the licensing of patented biotechnologies and health-related technologies: a justification -- 9. Patents and the public interest: a multi-faceted approach -- Index
000047645 520__ $$aThis book examines patent law and policy in biotechnology across the full lifecycle of the patent, focusing on the patent bargain and the public interest. It considers the central issues of how to strike an effective balance of rights, and whether public interest is adequately safeguarded - two issues that are particularly important in areas of rapidly emerging technology.  Expert contributors are brought together to explore patent eligibility in biotechnology, focusing on the fields of precision medicine, biofabrication and non-invasive prenatal testing. Chapters also explore the construction and coherence of exceptions to patentability,an examination of FRAND licensing in the context of the internet of medical things, and the possibility of using licensing to encourage or ensure the ethical use of patented technologies.  With its carefully constructed analysis, this book will be an excellent resource for academic researchers, and students, in the fields of biotechnology law, pharmaceutical law and intellectual property law. It will also be useful for legal practitioners and policymakers, as well as charitable bodies and non-governmental organisations.$$cProvided by publisher.
000047645 588__ $$aDescription based on print record.
000047645 650_4 $$aEnvironment$$xBiotechnology.
000047645 650_4 $$aInnovation and Technology$$xBiotechnology.
000047645 650_4 $$aIntellectual Property Law.
000047645 650_0 $$aPatents.
000047645 650_0 $$aInternet$$xLaw and legislation.
000047645 650_0 $$aIntellectual property.
000047645 655_0 $$aElectronic Books.
000047645 7001_ $$aHawkins, Naomi,$$eeditor.
000047645 7001_ $$aAboy, Mateo,$$eauthor.
000047645 85641 $$uhttps://www.elgaronline.com/display/book/9781800884410/9781800884410.xml$$yView eBook
000047645 904__ $$aBook
000047645 980__ $$aOS